Total Clarity Wealth Management, Inc. Exelixis, Inc. Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$17.44 - $23.16 $30,258 - $40,182	1,735 New	1,735 $36,000
Q1 2022 Apr 29, 2022	SELL	$17.03 - $22.67 $34,656 - $46,133	-2,035 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$15.84 - $21.88 $12,672 - $17,504	800 Added 64.78%	2,035 $37,000
Q3 2021 Oct 21, 2021	BUY	$16.3 - $21.14 $20,130 - $26,107	1,235 New	1,235 $26,000
Q2 2021 Jul 26, 2021	SELL	$17.95 - $25.56 $22,168 - $31,566	-1,235 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$20.53 - $25.22 $25,354 - $31,146	1,235 New	1,235 $28,000
Q1 2020 Apr 24, 2020	SELL	$14.46 - $21.8 $22,123 - $33,354	-1,530 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$15.15 - $18.89 $23,179 - $28,901	1,530 New	1,530 $27,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.